Insights PreviousNextSubscribe to HTA QuarterlyGet at-a-glance updates on important HTA decisions. Each edition of the HTA Quarterly provides insight into the evolving perspectives and priorities for HTAs.Read MoreSubscribe to Health Policy WeeklyRecaps legislative and regulatory developments and healthcare reform news that impacts the healthcare industry.Read More1 of 0 Items Upping the Game: How drug manufacturers, health systems and payers can collaborate more closely in the new world of patient-minded care.How can manufacturers collaborate with health systems to positively affect patient-minded care? How can health systems and manufacturers share information and expertise to improve the patient experience and outcomes? In this issue brief, we take a closer look at three anchors of collaboration: medication access for patients, medication adherence and transitional care. MoreUsing Data to Unlock the Patient ExperienceIn the healthcare arena, big data is an umbrella term that encompasses volumes of data related to patient health and well-being, disease diagnoses and progress, tests performed, lab results, medications prescribed or administered, side effects and more. The data sets that comprise big data are large, complex and unruly. Mike Eaddy, PharmD, PhD, Vice President of Real-world Evidence, breaks down what's needed to uncover meaningful data for meaningful conclusions. MoreAssessing Value in Oncology: Models & Perspectives from Payers and OncologistsIn this issue brief, we recap 3 value assessment models currently at the forefront of discussions in the US and provide some perspectives from payers and oncologists. MorePart B Drug Payment Change: Understanding the Implications for PharmaXcenda’s Jennifer Snow and Amanda Forys presented a webinar on March 28, 2016 focusing on what’s known about the proposed Medicare Part B Drug Payment Model, the biggest change in Medicare drug reimbursement in years. Learn what the implications are for pharmaceutical manufacturers and the strategies to demonstrate product value in today’s evolving market. MoreOncology in the Era of Value Frameworks: Perspectives from Payers and Oncologists & Implications for Product PlanningRecorded on December 10, 2015, Douglas Neely and Lisa Bloudek provide insights on how value frameworks are currently perceived through sharing of comprehensive survey data from oncologists and payers. They strategies on how these frameworks can be leveraged by manufacturers to demonstrate product value, with a focus on the ASCO framework. MoreTry Out the HTA Decision MapXcenda's Decision Map makes it easy to stay informed on key HTA decisions from Australia, Canada, France, Germany, and the United Kingdom. MoreHTA Quarterly Archive: Insights to Bridge Science and PolicyFind articles from current and past issues of the HTA Quarterly, Xcenda's e-newsletter written specifically by and for health economics and market access professionals. MoreHealth Policy Weekly ArchiveMiss a recent issue? Get up to date with the latest regulatory and legislative happenings and news that impact stakeholders in the healthcare industry. More Explore More InsightsWe invite you to explore our library of articles, webcasts, white papers, and more.